Capital Group US Corporate Bond Fund (LUX) Z

Category USD Corporate Bond
star-filledstar-filledstar-filledstar-filled
This fund can be held in an Investment ISA, SIPP and Investment Account
Last buy/sell price

£8.98

arrow-up£0.05 (+0.56%)

Fund Code

CIUSA

BD5D9M9

LU1567059263

Prices updated as at 30 May 2025
|
Prices in GBP
Investment objective
The investment objective of the fund is to provide, over the long term, a high level of total return consistent with capital preservation and prudent risk management. The Fund invests primarily in USD-denominated corporate Investment Grade Bonds. These Bonds will be Investment Grade at the time of purchase.
Important notice: This product is based overseas and is not subject to UK sustainable investment labelling and disclosure requirements. Please refer to the FCA website which details further information in relation to sustainability disclosure requirements for retail clients.
Important documents: Please ensure that you have read the Key Information Document/Technical Guide
, Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and the fund information documents. These can be found within the Charges & documents section.

Portfolio as of 30/04/2025

Asset allocation

Created with Highcharts 7.2.2- Stocks95.33% Bonds4.67% Cash- Other0% Not classified
Show long & short position

Geographical breakdown

Continent or country allocation (%)

Created with Highcharts 7.2.2

  • Interest rate risk

    Bond %
    Avg credit qualityA
    Avg wtd coupon5
    Modified duration6.71

  • Credit quality breakdown

    Rating% of Bond
    AAA7.62
    AA13.28
    A48.18
    BBB30.89
    BB0.03
    B-
    Below B0
    Not Rated-

Valuation

Capital Group US Corporate Bond Fund (LUX) Z
USD Corporate Bond

-

-
-

-

-
-

-

-
-

-

-
-

Growth rate

Capital Group US Corporate Bond Fund (LUX) Z
USD Corporate Bond

-

-
-

-

-
-

-

-
-

Top 10 holdings

1
United States Treasury Notes 4.63%
Sector
-
Country
United States
% of assets
2.87807
2
Marsh & McLennan Companies, Inc. 5%
Sector
-
Country
United States
% of assets
1.71858
3
AbbVie Inc. 5.05%
Sector
-
Country
United States
% of assets
1.55959
4
Chubb INA Holdings Inc 5%
Sector
-
Country
United States
% of assets
1.28696
5
Boston Properties Limited Partnership 5.75%
Sector
-
Country
United States
% of assets
1.19117
6
Morgan Stanley 5.164%
Sector
-
Country
United States
% of assets
1.15671
7
Amgen Inc. 5.25%
Sector
-
Country
United States
% of assets
1.14611
8
Bristol-Myers Squibb Company 5.2%
Sector
-
Country
United States
% of assets
1.08769
9
CVS Health Corp 5.7%
Sector
-
Country
United States
% of assets
0.97842
10
Mars Inc. 5.2%
Sector
-
Country
United States
% of assets
0.97708
Assets in top 10 holdings %

13.98%

Total no. of equity holdings

-

Total no. of bond holdings

491.00

Stock sectors

Capital Group US Corporate Bond Fund (LUX) Z
USD Corporate Bond

0.00%

Basic materials

-
-

Con cyclical

-
-

Financial svs

-
-

Real estate

-
-

0.00%

Comm services

-
-

Energy

-
-

Industrials

-
-

Technology

-
-

0.00%

Con defensive

-
-

Healthcare

-
-

Utilities

-
-


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.


Any ESG-related information, methodologies, tools, ratings, data and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted, and Morningstar accepts no responsibility or liability whatsoever for the actions of third parties in this respect.
© Copyright 2025 Morningstar. All rights reserved.